Revvity news
The WiseView Research desk's stories that name Revvity, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The RVTY page →
- HeadlineWill Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?
- HeadlineRevvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- HeadlineELV vs. RVTY: Which Stock Is the Better Value Option?
- HeadlineRevvity Launches Signals LabGistics to Coordinate Scientific Workflows
- HeadlineRevvity: A Diagnostics Annuity Is Quietly Funding An AI Data Engine
- HeadlineRevvity to Present at Upcoming Investor Conferences
- CongressGilbert Cisneros sold $1,001 - $15,000 of RVTY
- CongressGilbert Cisneros sold $1,001 - $15,000 of RVTY
- CongressGilbert Cisneros sold $15,001 - $50,000 of RVTY
- HeadlineRevvity to Host Investor Day
- HeadlineRevvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?
- HeadlineRevvity to Hold Earnings Call on November 3, 2026
- HeadlineHere's Why You Should Retain Revvity Stock in Your Portfolio for Now
- CongressGilbert Cisneros bought $15,001 - $50,000 of RVTY
- CongressGilbert Cisneros bought $1,001 - $15,000 of RVTY
- CongressRo Khanna bought $1,001 - $15,000 of RVTY
- CongressGilbert Cisneros bought $1,001 - $15,000 of RVTY
- CongressRo Khanna sold $1,000 - $15,000 of RVTY
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.